Plethora Solutions Receives £1M Investment from Maven Capital Partners

Plethora Solutions (AIM: PLE), a London, UK-based pharmaceutical company dedicated to the development and marketing of products for the treatment and management of urological disorders, recently received a £1m investment from Maven Capital Partners.
The investment was made through the £75m UK Government backed Capital for Enterprise Fund, which was launched in 2009 to help small and medium size enterprises (SMEs) in the UK gain access to the financial support required to bridge the funding gap caused by the credit crisis.
The financing will provide Plethora with additional working capital for the expansion of The Urology Company, its new product marketing subsidiary.

Join the discussion